Abstract
Cancer is a heterogeneous disease, and sub-populations of cells can drive drug resistance. Fluorescence lifetime imaging of metabolic co-factors is used to monitor drug response on a cellular level, to optimize clinical treatment decisions.
© 2015 IEEE
PDF ArticleMore Like This
Melissa C. Skala
AW3H.4 CLEO: Applications and Technology (CLEO:A&T) 2015
Melissa C. Skala, Alex J. Walsh, Amy T. Shah, Joseph T. Sharick, Tiffany M. Heaster, Rebecca S. Cook, Carlos L. Arteaga, Melinda E. Sanders, and Ingrid Meszoely
JW4A.1 Cancer Imaging and Therapy (Cancer) 2016
Melissa C. Skala
NT4C.2 Novel Techniques in Microscopy (NTM) 2015